ADIPOQ and hepatocellular carcinoma: For example, adiponectin treatment has been shown to inhibit growth of HCC cells (HepG2, Huh7) in a dose-dependent manner; however, this effect was not observed when a normal human hepatocyte cell line (THLE-2) was treated with adiponectin [56].